106 related articles for article (PubMed ID: 8229497)
1. Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy.
Relling MV; Mulhern RK; Fairclough D; Baker D; Pui CH
J Pediatr; 1993 Nov; 123(5):811-6. PubMed ID: 8229497
[TBL] [Abstract][Full Text] [Related]
2. Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
Marshall G; Kerr S; Vowels M; O'Gorman-Hughes D; White L
J Pediatr; 1989 Jul; 115(1):156-60. PubMed ID: 2661789
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings.
Tyc VL; Mulhern RK; Fairclough D; Ward PM; Relling MV; Longmire W
J Dev Behav Pediatr; 1993 Aug; 14(4):236-41. PubMed ID: 8408666
[TBL] [Abstract][Full Text] [Related]
4. Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
Ono A; Kishimoto K; Hasegawa D; Goldman RD; Kosaka Y
Support Care Cancer; 2019 Mar; 27(3):895-899. PubMed ID: 30066198
[TBL] [Abstract][Full Text] [Related]
5. A randomized comparison of intravenously administered granisetron versus chlorpromazine plus dexamethasone in the prevention of ifosfamide-induced emesis in children.
Hählen K; Quintana E; Pinkerton CR; Cedar E
J Pediatr; 1995 Feb; 126(2):309-13. PubMed ID: 7844684
[TBL] [Abstract][Full Text] [Related]
6. Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial.
Kris MG; Gralla RJ; Clark RA; Tyson LB; Groshen S
Cancer; 1987 Dec; 60(11):2816-22. PubMed ID: 3315176
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron.
Holdsworth MT; Raisch DW; Winter SS; Chavez CM
Support Care Cancer; 1998 Mar; 6(2):132-8. PubMed ID: 9540172
[TBL] [Abstract][Full Text] [Related]
8. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia.
Holdsworth MT; Raisch DW; Duncan MH; Chavez CM; Leasure MM
Ann Pharmacother; 1995 Jan; 29(1):16-21. PubMed ID: 7711340
[TBL] [Abstract][Full Text] [Related]
9. Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesis.
Gordon CJ; Pazdur R; Ziccarelli A; Cummings G; Al-Sarraf M
Cancer; 1989 Feb; 63(3):578-82. PubMed ID: 2912533
[TBL] [Abstract][Full Text] [Related]
10. The antiemetic effect of lorazepam after outpatient strabismus surgery in children.
Khalil SN; Berry JM; Howard G; Lawson K; Hanis C; Mazow ML; Stanley TH
Anesthesiology; 1992 Nov; 77(5):915-9. PubMed ID: 1443746
[TBL] [Abstract][Full Text] [Related]
11. Teniposide (VM-26) and continuous infusion cytosine arabinoside for initial induction failure in childhood acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
Ochs J; Rivera GK; Pollock BH; Buchanan G; Crist W; Freeman AI
Cancer; 1990 Oct; 66(8):1671-7. PubMed ID: 2208021
[TBL] [Abstract][Full Text] [Related]
12. Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia.
Carden PA; Mitchell SL; Waters KD; Tiedemann K; Ekert H
J Clin Oncol; 1990 Sep; 8(9):1531-5. PubMed ID: 2144019
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
Dix S; Cord M; Howard S; Coon J; Belt R; Geller R
Bone Marrow Transplant; 1999 Sep; 24(5):561-6. PubMed ID: 10482943
[TBL] [Abstract][Full Text] [Related]
14. Somnolence, hypotension, and metabolic acidosis following high-dose teniposide treatment in children with leukemia.
McLeod HL; Baker DK; Pui CH; Rodman JH
Cancer Chemother Pharmacol; 1991; 29(2):150-4. PubMed ID: 1760858
[TBL] [Abstract][Full Text] [Related]
15. The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study.
Molino A; Guglielmo L; Azzolini ME; Biondani P; Capelli MC; Grandinetti A; Griso C; Martinelli G; Martini N; Zanotti R
Oncology; 1991; 48(2):111-5. PubMed ID: 1997932
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
[TBL] [Abstract][Full Text] [Related]
17. Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.
Siddique R; Hafiz MG; Rokeya B; Jamal CY; Islam A
Mymensingh Med J; 2011 Oct; 20(4):680-8. PubMed ID: 22081189
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Gilbert CJ; Ohly KV; Rosner G; Peters WP
Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
[TBL] [Abstract][Full Text] [Related]
19. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
20. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
